Literature DB >> 33322509

A Systematic Review on the Association of Acquired Human Cytomegalovirus Infection with Hearing Loss.

Estrella Martinez-Gomez1, Patricia Perez-Carpena1, Marisa Flook1, José A Lopez-Escamez1,2,3.   

Abstract

Congenital cytomegalovirus (CMV) infection induces a clinical syndrome usually associated with hearing loss. However, the effect of acquired CVM infection in adults and children has not been clearly defined. The objective of this review is to critically appraise scientific evidence regarding the association of acquired CMV infection with postnatal hearing loss or tinnitus. A systematic review of records reporting sensorineural hearing loss (SNHL) or tinnitus and acquired CMV infection including articles published in English was performed. Search strategy was limited to human studies with acquired CMV infection. After screening and quality assessment, nine studies involving 1528 individuals fulfilled the inclusion criteria. A total of 14% of patients with SNHL showed evidence of previous exposure to CMV, while in individuals without SNHL (controls) the percentage rose up to 19.3%. SNHL was reported as unilateral or bilateral in 15.3%, and not specified in 84.7% of cases. The degree of SNHL ranged from mild to profound for both children and adults. None of the records reported tinnitus. The prevalence of children or adults with acquired SNHL with a confirmed acquired CMV infection by Polymerase Chain Reaction (PCR) or IgM anti-CMV antibodies is low. Phenotyping of patients with acquired CMV infection was limited to hearing loss by pure tone audiometry and no additional audiological testing was performed in most of the studies. Additional symptoms deserve more attention, including episodic vertigo or tinnitus, since some patients with the clinical spectrum of Meniere Disease could result from a CMV latent infection.

Entities:  

Keywords:  cytomegalovirus; sensorineural hearing loss; systematic review; tinnitus

Year:  2020        PMID: 33322509      PMCID: PMC7764083          DOI: 10.3390/jcm9124011

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  40 in total

Review 1.  Meniere's disease might be an autoimmune condition?

Authors:  A Greco; A Gallo; M Fusconi; C Marinelli; G F Macri; M de Vincentiis
Journal:  Autoimmun Rev       Date:  2012-01-28       Impact factor: 9.754

2.  Enterovirus, cytomegalovirus, and Epstein-Barr virus infection screening in idiopathic sudden sensorineural hearing loss.

Authors:  Menachem Gross; Dana G Wolf; Josef Elidan; Ron Eliashar
Journal:  Audiol Neurootol       Date:  2007-01-25       Impact factor: 1.854

3.  Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants.

Authors:  Edyta Paradowska; Agnieszka Jabłońska; Mirosława Studzińska; Patrycja Suski; Beata Kasztelewicz; Barbara Zawilińska; Małgorzata Wiśniewska-Ligier; Katarzyna Dzierżanowska-Fangrat; Teresa Woźniakowska-Gęsicka; Justyna Czech-Kowalska; Bożena Lipka; Maria Kornacka; Dorota Pawlik; Tomasz Tomasik; Magdalena Kosz-Vnenchak; Zbigniew J Leśnikowski
Journal:  J Clin Virol       Date:  2013-06-25       Impact factor: 3.168

4.  Role of viral and Mycoplasma pneumoniae infection in idiopathic sudden sensorineural hearing loss.

Authors:  R Ramírez-Camacho; F Portero; J A Vargas
Journal:  Acta Otolaryngol       Date:  2000-10       Impact factor: 1.494

Review 5.  Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.

Authors:  Michael J Cannon; D Scott Schmid; Terri B Hyde
Journal:  Rev Med Virol       Date:  2010-07       Impact factor: 6.989

6.  The relationship of the herpesvirus family to sudden hearing loss: a prospective clinical study and literature review.

Authors:  W R Wilson
Journal:  Laryngoscope       Date:  1986-08       Impact factor: 3.325

7.  Cytomegalovirus (CMV) Infection Causes Degeneration of Cochlear Vasculature and Hearing Loss in a Mouse Model.

Authors:  Mattia Carraro; Ali Almishaal; Elaine Hillas; Matthew Firpo; Albert Park; Robert V Harrison
Journal:  J Assoc Res Otolaryngol       Date:  2016-12-19

8.  Sudden sensorineural hearing loss: subclinical viral and toxoplasmosis infections as aetiology and how they alter the clinical course.

Authors:  Dimitrios Kikidis; Thomas P Nikolopoulos; Georgios Kampessis; Georgios Stamatiou; Aristeidis Chrysovergis
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2011-03-08       Impact factor: 1.538

9.  Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections.

Authors:  Oriane Soetens; Christelle Vauloup-Fellous; Ina Foulon; Pascal Dubreuil; Ben De Saeger; Liliane Grangeot-Keros; Anne Naessens
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

10.  Outcome of Preterm Infants With Postnatal Cytomegalovirus Infection via Breast Milk: A Two-Year Prospective Follow-Up Study.

Authors:  Wai-Tim Jim; Nan-Chang Chiu; Che-Sheng Ho; Chyong-Hsin Shu; Jui-Hsing Chang; Han-Yang Hung; Hsin-An Kao; Hung-Yang Chang; Chun-Chih Peng; Bey-Hwa Yui; Chih-Pin Chuu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more
  3 in total

1.  Auditory evaluation of infants born to COVID19 positive mothers.

Authors:  Sara Ghiselli; Andrea Laborai; Giacomo Biasucci; Martina Carvelli; Daria Salsi; Domenico Cuda
Journal:  Am J Otolaryngol       Date:  2022-02-05       Impact factor: 1.808

Review 2.  Nanoparticles for the Treatment of Inner Ear Infections.

Authors:  Dan Cristian Gheorghe; Adelina-Gabriela Niculescu; Alexandra Cătălina Bîrcă; Alexandru Mihai Grumezescu
Journal:  Nanomaterials (Basel)       Date:  2021-05-17       Impact factor: 5.076

Review 3.  Early Life Inflammation and the Developing Hematopoietic and Immune Systems: The Cochlea as a Sensitive Indicator of Disruption.

Authors:  Kelly S Otsuka; Christopher Nielson; Matthew A Firpo; Albert H Park; Anna E Beaudin
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.